Sun Pharma Scores FDA Nod for Generic of Merck's Zetia

Jun 13, 2017

Sun Pharmaceutical Industries Ltd. announced in a press release that one of its wholly owned subsidiaries has received final approval from U.S. FDA for its Abbreviated New Drug Application (ANDA) for a generic version of Zetia, (ezetimibe) Tablets 10mg.

The generic ezetimibe tablets are therapeutic equivalents of Merck’s Zetia tablets, which are anti-cholesterol drugs. According to IMS, ezetimibe tablets had annual sales of about $2.7 billion for the 12 months ended April 2017.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments